CIDRAP newsletters options
A substantial reduction was seen in practices offering weekend hours or advanced-access scheduling.
Contacts of the patient are being closely monitored and offered preventive vaccination.
Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment options.
The rate of gonorrhea cases across Europe rose by 31% in 2023 compared with 2022, and is up 321% since 2014.
The global research agenda includes 33 research priorities for bacterial and fungal infections and 7 for drug-resistant tuberculosis.
The effect of financial incentives on primary and booster vaccinations was nonsignificant.
The rate of antiviral prescriptions was 67% lower in pregnant than in nonpregnant women, including those with 1 or more high-risk underlying conditions.
PAHO is tracking a rise in dengue serogroup 3 activity, which could raise the risk of severe illness as countries approach the peak of the season.
Children with previous COVID-19 infection have a 25% to 28% higher risk of developing new gastrointestinal tract symptoms for up to 2 years than kids who did not have COVID-19.
Test positivity topped 30%, with steady rises in emergency department visits and hospitalizations.
An estimated 68,315 hospitalizations, 13,108 ICU admissions, and 5,301 in-hospital deaths may have been prevented.
Of the 18 people sickened in this outbreak, 1 person has been hospitalized and no deaths have been reported.
Media reports indicate Gerald Parker, DVM, PhD, will lead the White House Office of Pandemic Preparedness and Response Policy.
AstraDx will receive $3 million to develop a test that detects and identifies pathogens and analyzes antimicrobial susceptibility in whole blood drawn from newborns.
Also, the CDC today said it has received reports of 14 cases so far this year from 5 jurisdictions.
The patient has recovered after hospitalization, and no exposure to pigs or related illnesses have been found.
The pooled prevalence of conjunctivitis in mpox was 9%, followed by impaired vision (4%), keratitis (3%), and eye lesions (3%).
Median hospital stay was longer in the RSV group than in flu patients.
Immunity after infection with pre-Omicron strains was 81%, regardless of symptoms, compared with 54% for Omicron.
Fighting has upended lab testing and sent mpox patients fleeing from treatment centers back into the community.
